Rallybio Corporation (RLYB) Misses Q4 EPS by 3c

Rallybio Corporation (NASDAQ: RLYB) reported Q4 EPS of ($0.50), $0.03 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says